Abstract
Background
Previous studies have demonstrated the neuroprotective effects of ethyl pyruvate in central nervous system (CNS) diseases. However, whether ethyl pyruvate attenuates early brain injury after subarachnoid hemorrhage (SAH) remains unknown. This study was conducted to investigate the potential effects of ethyl pyruvate on early brain injury induced by SAH and explore the underlying mechanisms.
Methods
Eighty-eight male Sprague-Dawley rats were used. An SAH model was induced by endovascular perforation. Ethyl pyruvate (100 mg/kg) or a vehicle was administered intraperitoneally at 1 h after SAH induction. SAH grade, neurological scores, brain water content, Evans blue extravasation, Western blots, and immunofluorescence were used to study the mechanisms of ethyl pyruvate.
Results
Ethyl pyruvate treatment inhibited microglia activation and reduced the expression of proinflammatory cytokines (IL-1β and TNF-α). Ethyl pyruvate treatment also prevented disruption of tight junction proteins (occluding and claudin-5) and reduced expression of MMP-9. In addition, ethyl pyruvate treatment markedly reduced TUNEL-positive cells and expression of cleaved caspase-3.
Conclusions
Our results indicated that ethyl pyruvate treatment attenuated early brain injury and improved neurological function after SAH by inhibiting microglia activation and apoptosis and stabilizing the BBB.
Similar content being viewed by others
References
Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH (2001) Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood–brain barrier and white matter components after cerebral ischemia. J Neurosci 21:7724–7732
Aslani F, Schuppe HC, Guazzone VA, Bhushan S, Wahle E, Lochnit G, Lustig L, Meinhardt A, Fijak M (2015) Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis. Hum Reprod 30:417–431
Bauer AT, Burgers HF, Rabie T, Marti HH (2010) Matrix metalloproteinase-9 mediates hypoxia-induced vascular leakage in the brain via tight junction rearrangement. J Cereb Blood Flow Metab 30:837–848
Cahill J, Calvert JW, Zhang JH (2006) Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab 26:1341–1353
Chen D, Wei XT, Guan JH, Yuan JW, Peng YT, Song L, Liu YH (2012) Inhibition of c-Jun N-terminal kinase prevents blood–brain barrier disruption and normalizes the expression of tight junction proteins clautin-5 and ZO-1 in a rat model of subarachnoid hemorrhage. Acta Neurochir (Wien) 154:1469–1476, discussion 1476
Chen J, Chen G, Li J, Qian C, Mo H, Gu C, Yan F, Yan W, Wang L (2014) Melatonin attenuates inflammatory response-induced brain edema in early brain injury following a subarachnoid hemorrhage: a possible role for the regulation of pro-inflammatory cytokines. J Pineal Res 57:340–347
Chen J, Wang L, Wu C, Hu Q, Gu C, Yan F, Li J, Yan W, Chen G (2014) Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage. J Pineal Res 56:12–19
Chen S, Feng H, Sherchan P, Klebe D, Zhao G, Sun X, Zhang J, Tang J, Zhang JH (2014) Controversies and evolving new mechanisms in subarachnoid hemorrhage. Prog Neurobiol 115C:64–91
Chen Y, Zhang Y, Tang J, Liu F, Hu Q, Luo C, Feng H, Zhang JH (2015) Norrin protected blood–brain barrier via frizzled-4/beta-catenin pathway after subarachnoid hemorrhage in rats. Stroke 46:529–536
Cho IH, Kim SW, Kim JB, Kim TK, Lee KW, Han PL, Lee JK (2006) Ethyl pyruvate attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. J Neurosci Res 84:1505–1511
Choi DK, Leem JG, Shin JW, Suh JH (2012) Effects of ethyl pyruvate on allodynia, TNF-alpha expression, and apoptosis in the dorsal root ganglion after spinal nerve ligation injury. Korean J Pain 25:213–220
Fujii M, Sherchan P, Soejima Y, Hasegawa Y, Flores J, Doycheva D, Zhang JH (2014) Cannabinoid receptor type 2 agonist attenuates apoptosis by activation of phosphorylated CREB-Bcl-2 pathway after subarachnoid hemorrhage in rats. Exp Neurol 261:396–403
Fujii M, Yan J, Rolland WB, Soejima Y, Caner B, Zhang JH (2013) Early brain injury, an evolving frontier in subarachnoid hemorrhage research. Transl Stroke Res 4:432–446
Garcia JH, Wagner S, Liu KF, Hu XJ (1995) Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation Stroke 26:627–634, discussion 635
Greenhalgh AD, Brough D, Robinson EM, Girard S, Rothwell NJ, Allan SM (2012) Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Dis Model Mech 5:823–833
Guo J, Zhang J, Luo X, Luo W, Lin C, Zhang K, Ji Y (2014) Effects of ethyl pyruvate on cardiac function recovery and apoptosis reduction after global cold ischemia and reperfusion. Exp Ther Med 7:1197–1202
Hasegawa Y, Suzuki H, Sozen T, Altay O, Zhang JH (2011) Apoptotic mechanisms for neuronal cells in early brain injury after subarachnoid hemorrhage. Acta Neurochir Suppl 110:43–48
Jang M, Lee MJ, Cho IH (2014) Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms. Brain Behav Immun 38:151–165
Kim HS, Cho IH, Kim JE, Shin YJ, Jeon JH, Kim Y, Yang YM, Lee KH, Lee JW, Lee WJ, Ye SK, Chung MH (2008) Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia. Free Radic Biol Med 45:950–963
Kim JB, Yu YM, Kim SW, Lee JK (2005) Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain. Brain Res 1060:188–192
Larysz-Brysz M, Lewin-Kowalik J, Czuba Z, Kotulska K, Olakowska E, Marcol W, Liskiewicz A, Jedrzejowska-Szypulka H (2012) Interleukin-1beta increases release of endothelin-1 and tumor necrosis factor as well as reactive oxygen species by peripheral leukocytes during experimental subarachnoid hemorrhage. Curr Neurovasc Res 9:159–166
Li Z, Liang G, Ma T, Li J, Wang P, Liu L, Yu B, Liu Y, Xue Y (2015) Blood–brain barrier permeability change and regulation mechanism after subarachnoid hemorrhage. Metab Brain Dis 30:597–603
Macdonald RL (2014) Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 10:44–58
Nag S, Kapadia A, Stewart DJ (2011) Review: molecular pathogenesis of blood–brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol 37:3–23
Ostrowski RP, Colohan AR, Zhang JH (2006) Molecular mechanisms of early brain injury after subarachnoid hemorrhage. Neurol Res 28:399–414
Pulathan Z, Altun G, Hemsinli D, Mentese A, Yulug E, Civelek A (2014) Role of ethyl pyruvate in systemic inflammatory response and lung injury in an experimental model of ruptured abdominal aortic aneurysm. Biomed Res Int 2014:857109
Sehba FA, Hou J, Pluta RM, Zhang JH (2012) The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 97:14–37
Sehba FA, Mostafa G, Knopman J, Friedrich V, Bederson JB (2004) Acute alterations in microvascular basal lamina after subarachnoid hemorrhage. J Neurosurg 101:633–640
Shi H, Wang HL, Pu HJ, Shi YJ, Zhang J, Zhang WT, Wang GH, Hu XM, Leak RK, Chen J, Gao YQ (2015) Ethyl Pyruvate Protects against Blood–brain Barrier Damage and Improves Long-term Neurological Outcomes in a Rat Model of Traumatic Brain Injury. CNS Neurosci Ther 21:374–384
Shin JH, Lee HK, Lee HB, Jin Y, Lee JK (2014) Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain. Neurosci Lett 558:159–163
Su X, Wang H, Zhu L, Zhao J, Pan H, Ji X (2013) Ethyl pyruvate ameliorates intracerebral hemorrhage-induced brain injury through anti-cell death and anti-inflammatory mechanisms. Neuroscience 245:99–108
Sugawara T, Ayer R, Jadhav V, Zhang JH (2008) A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 167:327–334
Yan F, Hu Q, Chen J, Wu C, Gu C, Chen G (2013) Progesterone attenuates early brain injury after subarachnoid hemorrhage in rats. Neurosci Lett 543:163–167
Yuksel S, Tosun YB, Cahill J, Solaroglu I (2012) Early brain injury following aneurysmal subarachnoid hemorrhage: emphasis on cellular apoptosis. Turk Neurosurg 22:529–533
Zhan Y, Krafft PR, Lekic T, Ma Q, Souvenir R, Zhang JH, Tang J (2015) Imatinib preserves blood–brain barrier integrity following experimental subarachnoid hemorrhage in rats. J Neurosci Res 93:94–103
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All experimental procedures for rats were approved by the Institutional Animal Care and Use Committee of Hangzhou Normal University and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest the subject matter or materials discussed in this manuscript.
Funding
No funding was received for this research.
Additional information
Comment
This study has the merit of focusing the research on aneurysmal subarachnoid hemorrhage (aSAH) on mechanisms of brain dysfunction that are different from cerebral vasospasm. Although cerebral vasospasm is still considered the principal cause of delayed neurological deterioration after aSAH, there is increasing scientific evidence that other pathogenetic mechanisms may play a role in determining delayed ischemia (1). Cerebral vasospasm and delayed ischemia could represent separate clinical entities both occurring in aSAH patients, but with different pathophysiologies and different relevance to the outcome. There are many hints confirming this hypothesis. Probably, the most evident is the fact that vasospasm is observed in most patients who suffer from aSAH, while only 20–30 % of them develop clinical symptoms. Another unequivocal piece of evidence showing that radiographic vasospasm and clinical outcome are not directly associated is the greater incidence of radiographic vasospasm in patients who undergo clipping as compared to those who receive endovascular treatment, but with similar results of the two techniques in terms of morbidity and mortality. These circumstances are widely recognized; nonetheless, they remain oddities that cannot be convincingly explained if we consider cerebral vasospasm as the only cause of delayed cerebral ischemia. Here the authors found that ethyl pyruvate alleviated behavioral dysfunction in experimental animals by inhibiting neural cell apoptosis and stabilizing the blood-brain barrier. These mechanisms, together with vasospasm, hypercoagulation, apoptosis, oxidative stress, cortical spreading depolarization, and inflammation, deserve further analysis concerning their role in the pathophysiology of neurological worsening after aSAH.
1. Tomasello F, Conti A (2015) The pathogenetic mechanism of delayed ischemic deficit in aneurysmal subarachnoid hemorrhage: a still-unsolved issue. World Neurosurg 84: 1207–1208.
Alfredo Conti
Messina, Italy
Rights and permissions
About this article
Cite this article
Fang, R., Zheng, X. & Zhang, M. Ethyl pyruvate alleviates early brain injury following subarachnoid hemorrhage in rats. Acta Neurochir 158, 1069–1076 (2016). https://doi.org/10.1007/s00701-016-2795-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-016-2795-3